Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$92.2

Avg closing price
Price range

4 Baillie Gifford Emergent Biosolutions Trades

Baillie Gifford started to build up the position in Emergent Biosolutions in Q4 2020 and continued to invest until Q1 2021. Since then they sold 423 shares. The investor completely sold their stake between Q3 2021 and Q1 2023.

Avg closing price
Price range
Sold -385 shares Q1 2023
Avg closing price $12.09
Price range $7.79 - $16.29
Sold 9.0% shares (-38 shares) Q3 2021
Avg closing price $60.56
Price range $50.07 - $66.05
Increased shares by 3.9% (+16 shares) Q1 2021
Avg closing price $102.42
Price range $86.23 - $125.19
New holding (+407 shares) Q4 2020
Avg closing price $91.78
Price range $79.17 - $111.47

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!